Search

everythinglearnresearchcommunity

for

Search:↓

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Wedelolactone may help treat chronic diseases due to its strong antioxidant properties.

The committee decided not to approve the drug due to low effectiveness and high risks.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Individualized treatments may help manage Dercum's disease symptoms.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

The treatment was ineffective in humans.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

Tadalafil and Finasteride may help treat aggressive melanoma.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Dutasteride may help reduce brain inflammation and improve cognition.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.